Literature DB >> 33118329

Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.

Shixiang Bao1, Shuai Jin1, Chunhua Wang2, Peipei Tu1, Kongwang Hu2, Jingtao Lu1,3.   

Abstract

Androgen receptor (AR) can suppress hepatocellular carcinoma (HCC) invasion and metastasis at an advanced stage. Vasculogenic mimicry (VM), a new vascularization pattern by which tumour tissues nourish themselves, is correlated with tumour progression and metastasis. Here, we investigated the effect of AR on the formation of VM and its mechanism in HCC. The results suggested that AR could down-regulate circular RNA (circRNA) 7, up-regulate micro RNA (miRNA) 7-5p, and suppress the formation of VM in HCC Small hairpin circR7 (ShcircR7) could reverse the impact on VM and expression of VE-cadherin and Notch4 increased by small interfering AR (shAR) in HCC, while inhibition of miR-7-5p blocked the formation of VM and expression of VE-cadherin and Notch4 decreased by AR overexpression (oeAR) in HCC. Mechanism dissection demonstrated that AR could directly target the circR7 host gene promoter to suppress circR7, and miR-7-5p might directly target the VE-cadherin and Notch4 3'UTR to suppress their expression in HCC. In addition, knockdown of Notch4 and/or VE-cadherin revealed that shVE-cadherin or shNotch4 alone could partially reverse the formation of HCC VM, while shVE-cadherin and shNotch4 together could completely suppress the formation of HCC VM. Those results indicate that AR could suppress the formation of HCC VM by down-regulating circRNA7/miRNA7-5p/VE-Cadherin/Notch4 signals in HCC, which will help in the design of novel therapies against HCC.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  Notch4; VE-Cadherin; androgen receptor; circRNA7; hepatocellular carcinoma; miRNA7-5p; vasculogenic mimicry

Mesh:

Substances:

Year:  2020        PMID: 33118329      PMCID: PMC7754040          DOI: 10.1111/jcmm.16022

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  36 in total

1.  JQ1 effectively inhibits vasculogenic mimicry of pancreatic ductal adenocarcinoma cells via the ERK1/2-MMP-2/9 signaling pathway both in vitro and in vivo.

Authors:  Meng Zhuo; Cuncun Yuan; Ting Han; Hai Hu; Jiujie Cui; Feng Jiao; Liwei Wang
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

2.  The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer.

Authors:  Qingmin Sun; Xi Zou; Ting Zhang; Jian Shen; Yongxiang Yin; Jingying Xiang
Journal:  Gynecol Oncol       Date:  2014-02-04       Impact factor: 5.482

3.  Gender disparity of hepatocellular carcinoma: the roles of sex hormones.

Authors:  Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

Review 4.  CircRNA: a novel type of biomarker for cancer.

Authors:  He-da Zhang; Lin-Hong Jiang; Da-Wei Sun; Jun-Chen Hou; Zhen-Ling Ji
Journal:  Breast Cancer       Date:  2017-07-18       Impact factor: 4.239

Review 5.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 6.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

7.  Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.

Authors:  Simona Camorani; Elvira Crescenzi; Matteo Gramanzini; Monica Fedele; Antonella Zannetti; Laura Cerchia
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

8.  Vasculogenic mimicry formation in EBV-associated epithelial malignancies.

Authors:  Tong Xiang; Yu-Xin Lin; Wenlong Ma; Hao-Jiong Zhang; Ke-Ming Chen; Gui-Ping He; Xiao Zhang; Miao Xu; Qi-Sheng Feng; Ming-Yuan Chen; Mu-Sheng Zeng; Yi-Xin Zeng; Lin Feng
Journal:  Nat Commun       Date:  2018-11-27       Impact factor: 14.919

9.  LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.

Authors:  Bing Shao; Xiulan Zhao; Tieju Liu; Yanhui Zhang; Ran Sun; Xueyi Dong; Fang Liu; Nan Zhao; Danfang Zhang; Lili Wu; Yong Wang; Meili Wang; Jie Meng; Xian Lin; Baocun Sun
Journal:  J Cell Mol Med       Date:  2018-12-01       Impact factor: 5.310

Review 10.  Tumor endothelial cells accelerate tumor metastasis.

Authors:  Nako Maishi; Kyoko Hida
Journal:  Cancer Sci       Date:  2017-08-17       Impact factor: 6.716

View more
  11 in total

Review 1.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

2.  Sex-specific changes in the expression of ER-alpha and androgen receptor with increasing tumor grade in patients with hepatocellular carcinoma.

Authors:  Caglar Berkel; Ercan Cacan
Journal:  Hum Cell       Date:  2022-03-29       Impact factor: 4.374

Review 3.  Androgen Receptor-Related Non-coding RNAs in Prostate Cancer.

Authors:  Yongyong Yang; Kilia Y Liu; Qi Liu; Qi Cao
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 4.  The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.

Authors:  Sha Qin; Yitao Mao; Xue Chen; Juxiong Xiao; Yan Qin; Luqing Zhao
Journal:  Int J Biol Sci       Date:  2021-07-22       Impact factor: 6.580

Review 5.  Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer.

Authors:  Mohammad Taheri; Tayyebeh Khoshbakht; Elena Jamali; Julia Kallenbach; Soudeh Ghafouri-Fard; Aria Baniahmad
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

Review 6.  The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases.

Authors:  Agnieszka Bielska; Anna Skwarska; Adam Kretowski; Magdalena Niemira
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 7.  The function and regulation network mechanism of circRNA in liver diseases.

Authors:  Panpan Wang; Yunhuan Zhang; Lugang Deng; Zhi Qu; Peisen Guo; Limin Liu; Zengli Yu; Peixi Wang; Nan Liu
Journal:  Cancer Cell Int       Date:  2022-03-31       Impact factor: 5.722

Review 8.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

Review 9.  MiR-7 in Cancer Development.

Authors:  Petra Korać; Mariastefania Antica; Maja Matulić
Journal:  Biomedicines       Date:  2021-03-23

10.  Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.

Authors:  Shixiang Bao; Shuai Jin; Chunhua Wang; Peipei Tu; Kongwang Hu; Jingtao Lu
Journal:  J Cell Mol Med       Date:  2020-10-28       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.